4AB:ETR
AbbVie Common Stock
241,50 €
arrow_downward
-1,27%(-3,10) 1D
8-окт., 10:21:35 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
244,30 €
High
244,30 €
Low
241,50 €
Mkt. cap
479,52 млд
Avg. vol.
672,00
Volume
264,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 миң
Open
244,30 €
High
244,30 €
Low
241,50 €
Mkt. cap
479,52 млд
Avg. vol.
672,00
Volume
264,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
WSJ
·
40 мүнөт мурун
Genmab Shares Climb After Positive Study Results for Blood-Cancer Drug
Benzinga
·
6 саат мурун
AbbVie Shares Rise After Hours on FDA Designations - AbbVie (NYSE:ABBV)
Investing.com
·
6 саат мурун
AbbVie options flow shows 4:1 call-to-put ratio as stock rises
Insider Monkey
·
12 саат мурун
Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com